1. Angiotensin‐converting‐enzyme insertion/deletion polymorphism, ACE activity, and COVID‐19: A rather controversial hypothesis. A case‐control study
- Author
-
A. Kominakis, Eftychia Polyzogopoulou, Georgios Antonakos, Christos Kroupis, Paraskevi Moutsatsou, Anastasia Antoniadou, Argirios E. Tsantes, Anna Papadopoulou, Sotirios Tsiodras, Vasiliki Papaevangelou, Apostolos Armaganidis, Ioanna Kokkinopoulou, Athina Nikolaidou, Eirini Maratou, Dimitra Dimopoulou, and Paraskevi C. Fragkou
- Subjects
medicine.medical_specialty ,Peptidyl-Dipeptidase A ,Severity of Illness Index ,SARS‐CoV‐2 ,Pathogenesis ,INDEL Mutation ,COVID‐19 ,Polymorphism (computer science) ,Virology ,Internal medicine ,Genotype ,medicine ,Humans ,ACE activity ,Risk factor ,Allele ,Pandemics ,Alleles ,Research Articles ,ACE ,Retrospective Studies ,angiotensin converting enzyme ,Polymorphism, Genetic ,biology ,business.industry ,Case-control study ,COVID-19 ,Angiotensin-converting enzyme ,ACE polymorphism ,Infectious Diseases ,Endocrinology ,Case-Control Studies ,Relative risk ,biology.protein ,business ,Research Article - Abstract
Accumulating data has shown a contribution of the renin‐angiotensin system in COVID‐19 pathogenesis. The role of angiotensin‐converting enzyme (ACE) insertion (I)/deletion (D) polymorphism as a risk factor in developing COVID‐19 disease comes from epidemiological data and is controversially discussed. We conducted a retrospective case‐control study and assessed the impact of ACE I/D genotype in COVID‐19 disease prevalence and severity. In 81 COVID‐19 patients explicitly characterized and 316 controls, recruited during the first wave of COVID‐19 pandemic, ACE I/D genotype, and ACE activity were determined. A generalized linear model was used and Poisson regression analysis estimated the risk ratios (RRs) of alleles and genotypes for disease severity. DD patients had almost 2.0‐fold increased risk (RR: 1.886, confidence limit [CL] 95%: 1.266–2.810, p = 0.0018) of developing a more severe disease when contrasted to ID and II individuals, as did D allele carriers compared to I carriers (RR: 1.372; CL 95%: 1.051–1.791; p = 0.0201). ACE activity (expressed as arbitrary units, AU/L) was lower in patients (3.62 ± 0.26) than in controls (4.65 ± 0.13) (p
- Published
- 2021
- Full Text
- View/download PDF